vimarsana.com

Page 181 - ஆரோக்கியம் பராமரிப்பு ஆம்ப் மருத்துவமனைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Citius Pharmaceuticals Announces $76 5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Share this article Share this article CRANFORD, N.J., Feb. 17, 2021 /PRNewswire/ Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) ( Citius or the Company ), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced that it has entered into definitive agreements with certain healthcare-focused and institutional investors for the purchase of an aggregate of 50,830,566 shares of its common stock and accompanying warrants to purchase up to an aggregate of 25,415,283 shares of its common stock, at a purchase price of $1.505 per share and accompanying warrant in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is expected to take place on or about February 19, 2021, subject to the satisfaction of customary closing conditions.

FibroGenesis Reports Positive Preclinical Data in Pancreatic and Breast Cancer Using Universal Acting Fibroblast Based Immunotherapy

FibroGenesis Reports Positive Preclinical Data in Pancreatic and Breast Cancer Using Universal Acting Fibroblast Based Immunotherapy USA - English News provided by Share this article Share this article HOUSTON, Feb. 17, 2021 /PRNewswire/ FibroGenesis, a clinical stage company developing fibroblast-based therapeutic solutions for unmet medical needs, announced today new data supporting utilizing its fibroblast-based immunotherapy for successful inhibition and induction of regression in preclinical models of breast cancer and pancreatic cancer.  Company scientists successfully replicated the process by which cancer coaxes fibroblasts to support its growth.  By manipulating these artificially generated cancer-associated-fibroblasts (CAFs) , the Company was able to generate an immunotherapy that teaches the immune system to selectively kill only fibroblasts which help tumors to grow.

Therabody Raises Strategic Investment To Advance Innovation And Accelerate Global Growth

Therabody Raises Strategic Investment To Advance Innovation And Accelerate Global Growth The Leader in Tech Wellness Secures Support from More Than 100 Influential People in Professional Sports, Culture, and Entertainment News provided by Share this article ™, formerly known as Theragun ®, the global leader and innovator in tech wellness, announced today it has raised equity from more than 100 names in sports, business, culture, and entertainment. The round includes investments from Shawn Carter (Jay-Z), Kevin Durant and The global group of investors includes nine current and former professional quarterbacks, as well as notable individuals spanning the worlds of sports and entertainment, many of whom already incorporate Therabody into their training, recovery, and overall wellness routines.  Other high-profile investors in the round include:

Apoteket AB starts selling Hydrocyn in Sweden

Apoteket AB starts selling Hydrocyn in Sweden News provided by Share this article Sweden s largest pharmacy Apoteket AB will start selling Bactiguard s disinfection solution Hydrocyn ® aqua (Hydrocyn) and the products will initially be available via the online store www.apoteket.se. Hydrocyn is a non-alcoholic product that effectively kills virus, bacteria and fungi without irritating the skin. Apoteket AB has a unique position in the Swedish market, both in terms of quality and customer service. The pandemic and the continued spread of virus and infections in society, means that there is a great need for products that are proven effective and at the same time work in everyday life. Therefore, we are very happy about the collaboration with Apoteket AB, which makes it possible to reach a broader group of customers, says Andreas Wallgren, General Manager Nordics at Bactiguard.

Pharmacy Technician Certification Board (PTCB) Launches Immunization Credential for Pharmacy Technicians

Pharmacy Technician Certification Board (PTCB) Launches Immunization Credential for Pharmacy Technicians Certificate demonstrates qualifications to administer COVID-19 vaccines News provided by Share this article Share this article WASHINGTON, Feb. 17, 2021 /PRNewswire/  As more pharmacies deliver COVID-19 vaccines across the US, the Pharmacy Technician Certification Board (PTCB), the nation s leading credentialing organization for pharmacy technicians, launches its new Assessment-Based Certificate in Immunization Administration, and is accepting applications now. The credential demonstrates a Certified Pharmacy Technician s (CPhT s) qualification to safely deliver immunizations and manage related tasks, including preparation, documentation, storage, and disposal. Pharmacy technicians are a critical component of the health care workforce that is administering and managing COVID-19 vaccines, said PTCB Executive Director and CEO William Schimmel. PTCB s Immunization Administ

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.